{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:45:46Z","timestamp":1789537546893,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901279"],"award-info":[{"award-number":["81901279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8217052229"],"award-info":[{"award-number":["8217052229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19ZR1445300"],"award-info":[{"award-number":["19ZR1445300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20S31904200"],"award-info":[{"award-number":["20S31904200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015359","name":"Shanghai Medical College, Fudan University","doi-asserted-by":"publisher","award":["FQXZ202106B"],"award-info":[{"award-number":["FQXZ202106B"]}],"id":[{"id":"10.13039\/501100015359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["CXTDA2017026"],"award-info":[{"award-number":["CXTDA2017026"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The lack of knowledge regarding the differences between Chinese and other ethnicities in the early manifestation of late-onset Pompe disease (LOPD) prohibits the development of an effective screening strategy. We conducted a multicenter screening study to determine LOPD prevalence in high-risk populations and define the early manifestation of LOPD in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between August 2020 and April 2021, the participants were prospectively identified through medical examination at 20 centers from inpatient departments and outpatient neuromuscular clinics in China. The inclusion criteria were as follows: (1) age \u2265 1 year and (2) either one of the following conditions: (a) persistent hyperCKemia, (b) muscle weakness of the axial and\/or limb-girdle muscles, or (c) unexplained restrictive respiratory insufficiency (RI). Enzymatic activity of acid \u03b1-glucosidase (GAA) was measured in a dried blood spot (DBS) using a tandem mass spectrometry (MS\/MS) assay. Next-generation sequencing (NGS) was used to evaluate all samples with decreased GAA activity, searching for <jats:italic>GAA<\/jats:italic> mutations and pseudodeficiency alleles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 492 cases, 26 positive samples (5.3%) were detected in the DBS test. Molecular studies confirmed a diagnosis of LOPD in eight cases (1.6%). Using MS\/MS assay, GAA activities in individuals with pseudodeficiency could be distinguished from those in patients with LOPD. The median interval from the onset of symptoms to diagnosis was 5 years. All patients also showed RI, with a mean forced vital capacity (FVC) of 48%, in addition to axial\/proximal muscle weakness. The creatine kinase (CK) level ranged from normal to no more than 5-fold the upper normal limit (UNL). LOPD with isolated hyperCKemia was not identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Less frequent hyperCKemia and predominant RI depict a different early portrait of adult Chinese patients with LOPD. A modified high-risk screening strategy should be proposed for the early diagnosis of Chinese patients with LOPD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.965207","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T07:30:17Z","timestamp":1664263817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["High-risk screening of late-onset Pompe disease: A different early portrait in China"],"prefix":"10.3389","volume":"13","author":[{"given":"Kexin","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyue","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":"G\u00fcng\u00f6r","year":"2011","journal-title":"Orphanet J Rare Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","volume":"269","author":"Berlit","year":"2022","journal-title":"J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","author":"Sch\u00fcller","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","author":"Kishnani","year":"2013","journal-title":"Am J Med Genet A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jmd2.12062","article-title":"Extent, impact, and predictors of diagnostic delay in Pompe disease: a combined survey approach to unveil the diagnostic odyssey","volume":"49","author":"Lagler","year":"2019","journal-title":"JIMD Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-019-1054-0","article-title":"Characteristics of pompe disease in china: a report from the Pompe registry","volume":"14","author":"Zhao","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/ane.13133","article-title":"Screening for late-onset Pompe disease in Poland","volume":"140","author":"Jastrzebska","year":"2019","journal-title":"Acta Neurol Scand."},{"key":"B9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nmd.2017.12.008","article-title":"A database for screening and registering late onset Pompe disease in Turkey","volume":"28","author":"Gokyigit","year":"2018","journal-title":"Neuromuscular Disorders."},{"key":"B10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.nmd.2017.03.005","article-title":"Targeted Population Screening of Late Onset Pompe Disease in Unspecified Myopathy Patients for Korean Population","volume":"27","author":"Lee","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.nmd.2017.03.010","article-title":"Screening for Pompe disease in a Portuguese high risk population","volume":"27","author":"Almeida","year":"2017","journal-title":"Neuromuscular Disorders."},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 Patients with hyperckemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperckemia using dried blood: a Spanish cohort","volume":"25","author":"Guti\u00e9rrez-Rivas","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jnnp-2014-310164","article-title":"Loped study: looking for an early diagnosis in a late-onset pompe disease high-risk population","volume":"87","author":"Musumeci","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ane.12811","article-title":"Screening for late-onset Pompe disease in western Denmark","volume":"137","author":"Hansen","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"B16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and Gaa gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying C","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","article-title":"Rapid progressive course of later-onset Pompe disease in Chinese patients","volume":"104","author":"Yang","year":"2011","journal-title":"Mol Genet Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1373\/clinchem.2011.164640","article-title":"Simplified newborn screening protocol for lysosomal storage disorders","volume":"57","author":"Metz","year":"2011","journal-title":"Clin Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1021\/ac900504s","article-title":"New strategy for the screening of lysosomal storage disorders: the use of the online trapping-and-cleanup liquid chromatography\/mass spectrometry","volume":"81","author":"la Marca","year":"2009","journal-title":"Anal Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.21037\/atm-21-3710","article-title":"Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann Trans Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.nmd.2016.09.004","article-title":"Clinical manifestation of late onset Pompe disease patients in Hong Kong","volume":"26","author":"Chu","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ymgme.2011.09.002","article-title":"Newborn screening for Pompe disease in Japan","volume":"104","author":"Oda","year":"2011","journal-title":"Mol Genet Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2009.03.004","article-title":"High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type ii in the Japanese population","volume":"97","author":"Kumamoto","year":"2009","journal-title":"Mol Genet Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/ncn3.12108","article-title":"Screening for late-onset Pompe disease in undiagnosed myopathies","volume":"5","author":"Matsui","year":"2017","journal-title":"Neurol Clin Neurosci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36197","article-title":"A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment","author":"Yang","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ymgme.2015.02.004","article-title":"Selva-O'Callaghan A, Grau-Junyent JM, Gallego-Galindo L, Coll MJ, Garcia-Morillo S, et al. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and\/or hyperckemia","volume":"114","author":"Perez-Lopez","year":"2015","journal-title":"Mol Genet Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset pompe's disease in patients with paucisymptomatic hyperckemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol Genet Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type ii (Gsdii): molecular identification of an Ivs1 (-13t\u2013>G) mutation in a majority of patients and a novel Ivs10 (+1gt\u2013>Ct) mutation","volume":"3","author":"Huie","year":"1994","journal-title":"Hum Mol Genet."},{"key":"B30","first-page":"887","article-title":"Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type ii","volume":"56","author":"Boerkoel","year":"1995","journal-title":"Am J Hum Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"Van Der Ploeg","year":"2017","journal-title":"Eur J Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nmd.2015.11.009","article-title":"Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease","volume":"26","author":"Johnson","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2016.05.018","article-title":"Progression from respiratory dysfunction to failure in late-onset Pompe disease","volume":"26","author":"Berger","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","article-title":"Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years","volume":"259","author":"Angelini","year":"2012","journal-title":"J Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1756285613487570","article-title":"Therapeutic advances in the management of Pompe disease and other metabolic myopathies","volume":"6","author":"Angelini","year":"2013","journal-title":"Ther Adv Neurol Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.4081\/ejtm.2021.9798","article-title":"Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from epoc consortium","volume":"31","author":"Angelini","year":"2021","journal-title":"Eur J Transl Myol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"M\u00fcller-Felber","year":"2007","journal-title":"Neuromuscul Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2007.05.011","article-title":"Glycogen storage disease type ii in Spanish patients: high frequency of C.1076-1g>C mutation","volume":"92","author":"Gort","year":"2007","journal-title":"Mol Genet Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.3233\/JND-159033","article-title":"Changing characteristics of late-onset Pompe Disease patients in italy: data from the Pompe registry","volume":"2","author":"Angelini","year":"2015","journal-title":"J Neuromuscul Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/humu.24272","article-title":"Broad variation in phenotypes for common Gaa genotypes in Pompe disease","volume":"42","author":"Ni\u00f1o","year":"2021","journal-title":"Hum Mutat."},{"key":"B41","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe Disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/GIM.0b013e3181d2900e","article-title":"The angiotensin-converting enzyme insertion\/deletion polymorphism modifies the clinical outcome in patients with Pompe disease","volume":"12","author":"de Filippi","year":"2010","journal-title":"Genet Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.965207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T07:30:21Z","timestamp":1664263821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.965207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":42,"alternative-id":["10.3389\/fneur.2022.965207"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.965207","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"article-number":"965207"}}